Anteris Technologies Global (AVR) Non Operating Interest Expenses (2024 - 2026)
Anteris Technologies Global's (AVR) quarterly Non Operating Interest Expenses came in at $131000.0 in Q2 2026, up 495.45% year-over-year from $22000.0 in Q2 2025, and up 385.19% quarter-over-quarter from $27000.0 in Q1 2026.
Analysis
Anteris Technologies Global (AVR) Non Operating Interest Expenses (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has reported Non Operating Interest Expenses for 3 consecutive years, with $131000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non Operating Interest Expenses rose 495.45% year-over-year to $131000.0 in Q2 2026; TTM through Jun 2026 was $183000.0, a 173.13% increase from a year earlier, with the FY2025 full-year figure at $73000.0, up 55.32% from the prior year.
- Non Operating Interest Expenses was $131000.0 for Q2 2026 at Anteris Technologies Global, up from $27000.0 in the prior quarter.
- Over five years, Non Operating Interest Expenses peaked at $131000.0 in Q2 2026 and troughed at $8000.0 in Q4 2024.
- A 3-year average of $27800.0 and a median of $16000.0 in 2024 frame the typical range for Non Operating Interest Expenses.
- The widest YoY moves for Non Operating Interest Expenses: up 495.45% in 2026, down 3.85% in 2026.
- Over 3 years, Non Operating Interest Expenses stood at $8000.0 in 2024, then gained by 25.0% to $10000.0 in 2025, then surged by 1210.0% to $131000.0 in 2026.
- The last three Non Operating Interest Expenses figures came in at $131000.0 (Q2 2026), $27000.0 (Q1 2026), and $10000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.05 Bn | 174.44 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 127.97 Bn | 122.75 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.27 Bn | 108.45 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 103.98 Bn | 100.50 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 63.03 Bn | 62.49 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.93 Bn | 31.47 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.26 Bn | 30.31 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Anteris Technologies Global | 812.79 Mn | 812.79 Mn | 776,000.00 | 131,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 131,000.00 |
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 26,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 17,000.00 |